Search clinical trials for: Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses
Total 13 results
-
PATHCompleted
-
AerasCrucell Holland BVCompletedTuberculosisSouth Africa
-
Auro Vaccines LLCUnited States Department of Defense; AccelovanceCompletedEbola Virus DiseaseUnited States
-
Emergent BioSolutionsCompleted
-
Crucell Holland BVThe PATH Malaria Vaccine Initiative (MVI); Seattle Children's Research Institute...Completed
-
Merck Sharp & Dohme LLCCompleted
-
University of Michigan Rogel Cancer CenterRush University Medical CenterCompletedPancreatic CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedHypoxic Ischemic EncephalopathyFrance
-
Medical University of ViennaCompletedVaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization TreatmentAustria
-
Oslo University HospitalVestre VikenHF Kongsberg SykehusRecruitingOpioid Use | Affective SymptomsNorway
-
Baskent UniversityCompletedElective Caesarean Section SurgeriesTurkey
-
Stanford UniversityCompletedLymphoma | Hodgkin Disease | Lymphoma, Hodgkin Disease | Lymphoma: HodgkinUnited States
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre LaboratoriesActive, not recruitingPrimary Central Nervous System LymphomaFrance